As of 2024-07-27, the Relative Valuation of AxoGen Inc (AXGN) is (16.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.24 USD, the upside of AxoGen Inc based on Relative Valuation is -274.8%.
The range of the Relative Valuation is (16.50) - (16.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.9x - 41.0x | 36.2x |
| Forward P/E multiples | 25.7x - 32.9x | 30.2x |
| Fair Price | (16.50) - (16.03) | (16.15) |
| Upside | -278.5% - -273.5% | -274.8% |
| Date | P/E |
| 2024-07-26 | -18.98 |
| 2024-07-25 | -19.16 |
| 2024-07-24 | -19.04 |
| 2024-07-23 | -19.41 |
| 2024-07-22 | -18.98 |
| 2024-07-19 | -18.73 |
| 2024-07-18 | -18.42 |
| 2024-07-17 | -19.47 |
| 2024-07-16 | -18.85 |
| 2024-07-15 | -17.79 |
| 2024-07-12 | -16.96 |
| 2024-07-11 | -17.11 |
| 2024-07-10 | -15.81 |
| 2024-07-09 | -15.79 |
| 2024-07-08 | -15.61 |
| 2024-07-05 | -15.49 |
| 2024-07-03 | -15.73 |
| 2024-07-02 | -15.44 |
| 2024-07-01 | -15.83 |
| 2024-06-28 | -14.87 |
| 2024-06-27 | -14.83 |
| 2024-06-26 | -15.40 |
| 2024-06-25 | -14.95 |
| 2024-06-24 | -14.85 |
| 2024-06-21 | -14.38 |
| 2024-06-20 | -13.99 |
| 2024-06-18 | -14.68 |
| 2024-06-17 | -15.22 |
| 2024-06-14 | -15.69 |
| 2024-06-13 | -16.08 |
| 2024-06-12 | -16.55 |
| 2024-06-11 | -15.16 |
| 2024-06-10 | -14.38 |
| 2024-06-07 | -14.31 |
| 2024-06-06 | -14.46 |
| 2024-06-05 | -14.38 |
| 2024-06-04 | -14.09 |
| 2024-06-03 | -14.01 |
| 2024-05-31 | -14.03 |
| 2024-05-30 | -14.38 |
| 2024-05-29 | -13.78 |
| 2024-05-28 | -13.64 |
| 2024-05-24 | -12.88 |
| 2024-05-23 | -12.55 |
| 2024-05-22 | -12.73 |
| 2024-05-21 | -12.51 |
| 2024-05-20 | -12.73 |
| 2024-05-17 | -12.40 |
| 2024-05-16 | -12.26 |
| 2024-05-15 | -12.22 |